ProfileGDS5822 / ILMN_2577977
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 47% 52% 50% 57% 59% 47% 38% 36% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 120.847
GSM1276600PDAC Late Ablation Control 225.252
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 119.750
GSM1276603PDAC Late Ablation 227.557
GSM1276604PDAC Late Ablation 331.959
GSM1303940PDAC Late Ablation_anti-CTLA4 120.947
GSM1303941PDAC Late Ablation_anti-CTLA4 218.338
GSM1303942PDAC Late Ablation_anti-CTLA4 317.436